ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[이데일리] [큐로셀 대해부]②“CAR-T 효능 높이는 오비스 기술로 타제품 이긴다”
2022/04/20
[큐로셀 대해부]②“CAR-T 효능 높이는 오비스 기술로 타제품 이긴다” (edaily.co.kr)
Prev
[이데일리] [큐로셀 대해부]①”우리가 CAR-T 선두, 개발·생산 모든 능력 갖춰”
Next
[이데일리] [큐로셀 대해부]③“상장되면?…2차 치료제용 CAR-T 임상도 도전”[이데일리]
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.